Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Orally bioavailable, brain-penetrant compound with selectivity for the cannabinoid type 2 receptor with potential use towards visceral pain management and neurodegenerative disorders

US Patent 12060358 · Granted Aug 13, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →